Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q2–2024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide...

Full description

Saved in:
Bibliographic Details
Main Authors: He Chen, Sixing Liu, Shuai Gao, Hangyu Shi, Yan Yan, Yixing Xu, Jiufei Fang, Weiming Wang, Huan Chen, Zhishun Liu
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Neurological adverse events
GLP-1 receptor agonists
Pharmacovigilance
FAERS database
Disproportionality analysis
Diabetes
Online Access:https://doi.org/10.1038/s41598-025-01206-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-01206-9

Similar Items